Skip to main content
Fig. 3 | International Journal of Retina and Vitreous

Fig. 3

From: Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties

Fig. 3

Faricimab ran on SDS-PAGE next to a (a) Spectra Multicolor High Range Protein Ladder under non-reducing (b-f) and reducing conditions (g-k). For all runs, the ladder is found to the left, followed by a vial sample and either 9 D0-n samples (b, g), D7-n samples (c, h), D7-c samples (d, i), D14-c samples (e, j), or D37-c samples (f, k). As a reference, we ran the gels next to a Spectra Multicolor Broad Range Protein Ladder after the study day, to confirm the size with a lower range standard (Supplementary material). D = day, n = needle, c = cap

Back to article page

International Journal of Retina and Vitreous

ISSN: 2056-9920

Contact us